Fig. 4: Plasma ctDNA and MTB correlation.

a, b Correlation between ctDNA levels and MTB in melanoma patients treated with combination BRAF/MEKi-targeted therapies at baseline (a) and radiological detection of progression (b). Pearson’s correlation coefficient and P values are indicated for each comparison.